SCHEMBL5380243

SCHEMBL5380243

Cc1cc(OC2CCN(Cc3ccccc3)C2)n2nc(-c3ccccc3Cl)c(-c3ccc(Cl)cc3)c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PDE2A O00408 6/20 0.41
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
DRD2 P14416 3/20 0.39
DRD4 P21917 3/20 0.39
DRD3 P35462 3/20 0.39
CNR1 P21554 2/20 0.38
MCHR1 Q99705 2/20 0.38
CRHR1 P34998 1/20 0.37
CHEK2 O96017 1/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841478 0.87 DRD4 (0.41) ALDH1A1HPGDKDM4EPDE2ASMN1; SMN2
SCHEMBL5669316 0.86 MCHR1 (0.39) KDM4ENPSR1DRD2DRD4DRD3
SCHEMBL5375132 0.83 CNR1 (0.40) ALDH1A1HPGDKDM4ENPSR1MAPT
SCHEMBL5382502 0.82 HSD17B10 (0.41) ALDH1A1HPGDKDM4ENPSR1MAPT
SCHEMBL5375929 0.76 MAPT (0.45) ALDH1A1HPGDKDM4ENPSR1MAPT
SCHEMBL5375242 0.74 MAPT (0.64) ALDH1A1HPGDKDM4ENPSR1MAPT
SCHEMBL14577345 0.74 MEN1 (0.62) ALDH1A1HPGDKDM4ENPSR1MAPT
SCHEMBL5391337 0.72 MAPT (0.49) ALDH1A1HPGDKDM4ENPSR1MAPT
SCHEMBL5380598 0.72 KMT2A (0.48) ALDH1A1HPGDKDM4ENPSR1MAPT
SCHEMBL5391857 0.71 KMT2A (0.56) ALDH1A1HPGDKDM4ENPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7176210-B2 Cannabinoid receptor ligands and uses thereof PFIZER INC. (US) 2007-02-13 US claimed
US-20040157838-A1 Cannabinoid receptor ligands and uses thereof PFIZER INC 2004-08-12 US claimed
US-7176210-B2 Cannabinoid receptor ligands and uses thereof PFIZER INC. (US) 2007-02-13 US disclosed
US-20040157838-A1 Cannabinoid receptor ligands and uses thereof PFIZER INC 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157838-A1 Cannabinoid receptor ligands and uses thereof CNR1, CNR2, GPR18 ALDH1A1 1683/4885HPGD 1567/4885KDM4E 3361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.